Start-Up Spotlight

South Korean start-up Mediwhale is using AI-guided retinal scans to predict the risk of eye, cardiovascular and kidney diseases. The company has moved ahead of a small pack of competitors and gained regulatory approval and market access in eight territories through a focus on gathering strong evidence to support algorithms.

Using artificial intelligence and coronary computed tomography angiography Cleerly is trying to shift cardiology's focus from symptoms-based interventions to prevention and treatment of the underlying vascular disease.

The company has developed a highly-customizable polymer that can repair tissue, negating the need for stitches and staples, for use in multiple applications.

Sparta Biomedical is developing a synthetic cartilage-on-titanium knee implant based on its proprietary Galene process for infusing cellulose fibers with polyvinyl alcohol. The company hopes to begin clinical trials in 2023.

Pyx Health’s is helping people overcome loneliness with a friendly interactive chatbot as well as human support staff that can connect users to resources and appropriate care.

Nothing except a name, but Creo Medical says its Speedboat Inject device can turn some surgeries from prolonged hospital stays into one-day visits.  

Dafna Presler, the VP-marketing at Intuition Robotics, talked to Medtech Insight about what the company has learned so far about its customers since launching ElliQ, a digital “sidekick” to help older people be healthy.

The Glaswegian company is tackling a tricky area of health care with its intelligent sensor and cloud processing technologies.

Cala Health’s FDA-cleared Cala Trio wearable for treating essential tremor is currently being tested in Parkinson’s disease patients and is targeting a $20bn global market opportunity.

The money will be used to further clinical research for its innovative, drug releasing, bone grafting products.